Cellular Goods PLC (LSE:CBX, FRA:6XS)'s (LON:CBX) Alexis Abraham talks to Proactive London's Katie Pilbeam about signing a multi-year manufacture and supply agreement with Chanelle McCoy Health Ltd (CMH).
As Abraham explains 'we identified an opportunity with a company that very much shared our values' to bring forward the launch of a range of clinically validated ingestible products to the fourth quarter of 2021.
The deal will introduce consumers to novel food compliant CBD ingestibles that Abraham believes will complement their CBG skincare range.